Biotech and Pharmaceuticals Medicine

  • Sen. Grassley: Mylan's EpiPen response 'incomplete'

    CNBC's Meg Tirrell reports the latest on the response from EpiPen maker Mylan to Sen. Chuck Grassley's inquiries over the controversial price hike for the drug.

  • Trojan Horse

    Government involvement in drug pricing is a Trojan horse that could lead to fewer drugs being invented, analyst David Maris says.

  • Sept 8- German chemicals and crop pesticides firm Bayer AG is exploring the sale of its dermatology business to push forward its deal with Monsanto Co, Bloomberg reported, citing sources. Bayer is working with JPMorgan Chase& Co on the sale, which could fetch more than 1 billion euros, the report said. The dermatology business could attract interest from existing...

  • WASHINGTON, Sept 8- On April 5, 2012, a criminal investigator from the Food and Drug Administration named Robert West charged into an oncology clinic in Greenville, Tennessee. West told Posey Sen she was guilty of buying counterfeit drugs and looked like a "deer in the headlights," court records say. Earlier that year, managers at the FDA's Maryland- based Office of...

  • WASHINGTON, Sept 8- On April 5, 2012, a criminal investigator from the Food and Drug Administration named Robert West charged into an oncology clinic in Greenville, Tennessee. West told Posey Sen she was guilty of buying counterfeit drugs and looked like a "deer in the headlights," court records say. Earlier that year, managers at the FDA's Maryland- based Office of...

  • LONDON, Sept 7- Scrub typhus, a deadly disease common in southeast Asia and spread by microscopic biting mites known as chiggers, has now taken hold in a part of South America and may have become endemic there, scientists said on Wednesday. The tropical disease, which kills at least 140,000 people a year in the Asia-Pacific region, has been confirmed in a cluster of...

  • Hospitals on average charged more than 20 times their own costs

    According to new research from the Johns Hopkins University, hospitals on average charged more than 20 times their own costs in 2013 in their CT scan and anesthesiology departments. Here's why.

  • Sept 7- The U.S. Centers for Disease Control and Prevention in 2013 released a list of drug-resistant bacterial and fungal infections, labeling each as "urgent," "serious" or "concerning," reflecting how dangerous they are, how prevalent and how difficult to treat. Most bacteria are classified as either Gram positive or Gram negative, depending on how they react to a...

  • Sept 7- The U.S. Centers for Disease Control and Prevention in 2013 released a list of drug-resistant bacterial and fungal infections, labeling each as "urgent," "serious" or "concerning," reflecting how dangerous they are, how prevalent and how difficult to treat. Most bacteria are classified as either Gram positive or Gram negative, depending on how they react to a...

  • ATLANTA, Ga., Sept 7- In 2013, the U.S. Centers for Disease Control and Prevention released estimates of how many people in the country die every year from antibiotic resistant infections: 23,000. The agency estimates that an additional 15,000 die annually from Clostridium difficile, an infection linked to long-term antibiotic use. The estimates, the agency...

  • Sept 7- The CDC documented the first AIDS cases in 1981. Within three years, most state health departments required hospitals and physicians to report and name each new diagnosis. "AIDS was constantly increasing," said Mervyn Silverman, San Francisco's director of health from 1977 to 1985. "AIDS cases became a few thousand, then 20,000, and it scared the hell out of...

  • Sept 7- The CDC documented the first AIDS cases in 1981. Within three years, most state health departments required hospitals and physicians to report and name each new diagnosis. "AIDS was constantly increasing," said Mervyn Silverman, San Francisco's director of health from 1977 to 1985. "AIDS cases became a few thousand, then 20,000, and it scared the hell out of...

  • RICHMOND, Va., Sept 7- Josiah Cooper-Pope, born 15 weeks premature, did fine in the neonatal intensive care unit for the first 10 days of his life. His mother, Shala Bowser, said nurses at Chippenham Hospital in Richmond, Virginia, told her that Josiah had an infection and that she should prepare for the worst. The shock of her son's death came back to her when, after being...

  • *Singapore has one of the world's lowest birth rates. "I really love kids and want to have one of my own," the 37- year-old who declined to give her full name said after a procedure at the fertility clinic of KK Women's and Children's Hospital, the largest facility for women's health in Singapore. The mosquito-borne virus has been linked to a spike in microcephaly, a...

  • *Drug fails late-stage trial for fibromyalgia. Sept 6- Tonix Pharmaceuticals Holding Corp said it would stop developing its drug for fibromyalgia after the treatment failed in a late-stage trial, sending its shares down nearly 60 percent. The drug has shown a stronger effect on PTSD patients than on those suffering from fibromyalgia, Chief Executive Seth...

  • What brought Theranos down

    Nick Bilton, Vanity Fair, discusses his article on Elizabeth Holmes and what happened inside Thernos.

  • LONDON, Sept 6- An experimental three-in-one inhaled drug from GlaxoSmithKline significantly cut flare-ups in patients with chronic lung disease in a clinical trial, researchers said on Tuesday. Although there is some debate as to how doctors would decide when to move patients onto triple therapy, GSK views the new inhaler as a big opportunity and CEO Andrew...

  • Sept 6- Tonix Pharmaceuticals Holding Corp said it would stop developing its drug for fibromyalgia and focus on a late-stage trial testing the treatment in patients with post-traumatic stress disorder. If the drug succeeds in a late-stage trial in PTSD patients and is approved by the U.S. Food and Drug Administration, it would be the first new treatment for the...

  • Hospital

    German health care group Fresenius is buying Spain's biggest private hospital chain Quironsalud for 5.8 billion euros.

  • LONDON, Sept 5- AstraZeneca hopes to convince doctors its experimental injection for severe asthma has an edge over two approved rivals after clinical trials data on Monday showed it worked well when given just once every two months. The drugmaker has previously flagged benralizumab, which is likely to reach the market next year, as a potential $2 billion-...